The Fortunes of Amgen: Analyzing the Relative Strength Index

Avatar photo

In the world of investments, sage counsel from legendary financier Warren Buffett is often reiterated: be apprehensive when the crowd is exuberant, and be voracious when the masses are anxious. One can gauge the prevailing sentiment in a stock by employing technical tools like the Relative Strength Index (RSI), a metric that gauges momentum on a 0 to 100 scale. When the RSI value falls below 30, a stock is deemed oversold.

During the recent trading session, Amgen Inc (Symbol: AMGN) found itself in oversold territory, registering an RSI of 29.6, after plummeting to $269.66 per share. To put this in perspective, the RSI for the S&P 500 ETF (SPY) currently stands at 54.9. An optimistic investor may interpret AMGN’s RSI of 29.6 as a signal that the intense selling pressure may be tapering off, presenting potential buying opportunities on the horizon. The visual representation below illustrates AMGN’s performance over the past year:

Amgen Inc 1 Year Performance Chart

Taking a closer look at the chart, the lower end of AMGN’s 52-week spectrum sits at $211.71 per share, while the upper threshold lingers at $329.72 — in stark contrast to the recent closing trade value of $268.87.

Discover more about 9 other oversold stocks that demand your attention »

Further Reading:

• OPTN Average Annual Return
• Top Ten Hedge Funds Holding RRM
• CSX Videos

The thoughts and perspectives voiced herein belong to the author alone and may not necessarily mirror those of Nasdaq, Inc.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now